Pembrolizumab,Vibostolimab,Gebasaxturev,MK-4830,Favezelimab
Merck
['melanoma', 'pembro']
great presentation on melanoma continuing trend of moving anti-pd1 approaches into curative setting. early data in pembro combos in neoadjuvant melanoma with tigit and oncolytic virus 
Professor, Medical Oncology @UCSD; PI @Patel_Lab computational immunopathology; Phase 1 & thoracic/NSCLC immunotherapy, solid tumor cell therapy, irAEs (he/him)